Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

November 1, 2024

Conditions
Cardiac Ischemia
Interventions
BIOLOGICAL

Ringer acetate based Del Nido cardioplegia

All patients will receive hypothermia 29 - 32 ℃ and cardioplegia will be injected between the aortic valve and aortic cross clamp in a pressure not less than 50 mmHg above systolic pressure. After removal of aortic cross clamping, the heart will be monitored for ventricular arrhythmias, early recovery, and postoperative 24 hours serum troponin and new changes in echocardiography.

BIOLOGICAL

HTK

Giving HTK instead of Del Nido

All Listed Sponsors
collaborator

Ahmed Ismail Abdelsabour

UNKNOWN

collaborator

Ramy Mustafa Abdelgawad Mohamed

UNKNOWN

collaborator

Ibrahim Mohamed Imbaby

UNKNOWN

collaborator

Amr Ibrahim Abdelaal

UNKNOWN

collaborator

Mahmoud Mohamed Atef Sallam

UNKNOWN

collaborator

Mohamed, Ahmed Abdelhay Mohamed

UNKNOWN

lead

Assiut University

OTHER

NCT06414330 - Ringer Acetate Based Modified Del Nido Cardioplegia Solution Versus HTK Solution Cardioplegia Solution in Cardiac Surgery | Biotech Hunter | Biotech Hunter